About pcm

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Meet the Professor more

Prof. Stephen M. Hahn: the important role of radiation oncology in precision oncology More >>
Dr. Philippe Lambin: how advances in imaging impact precision radiation oncology More >>
Dr. Bhadrasain Vikram: future road of radiation—radiomics and genomics will play important roles More >>
Case Report of Precision Oncology Tumor Board 
Exploiting homologous recombination repair alterations in metastatic castrate-resistant prostate cancer: a case report and literature review
Stephen Zachary Peeke, Robert Lopez, Benjamin Gartrell
Precision Cancer Medicine  
2020;
3:
10  
Case Report: Precision Oncology Tumor Board 
Utilizing genomic profiling in a patient with a thoracic malignancy of uncertain primary: case report
Jose N. Galeas, Nishi Shah, Shabnam Ridvi, Jennifer Chuy
Precision Cancer Medicine  
2020;
3:
9  
Case Report: Precision Oncology Tumor Board 
Targeting EGFR mutations needs to be more precise with co-mutations
Paul R. Walker, Nitika Sharma, Praveen Namireddy
Precision Cancer Medicine  
2020;
3:
8  
Review Article 
Non-small cell lung cancer PDL1 >50%—should we go single or combo?
Waleed Kian, Laila C. Roisman, Dina Levitas, Nadav Wallach, Adam Abo-Sharb, Aharon Y. Cohen, Alexander Yakobson, Nir Peled, Yulia Dudnik
Precision Cancer Medicine  
2020;
3:
7  
Review Article 
Annotating the next generation sequencing report
Miguel A. Molina-Vila, Clara Mayo-de-las-Casas, Mónica Garzón-Ibáñez, Núria Jordana-Ariza, Beatriz García-Peláez, Ariadna Balada-Bel, Rafael Rosell
Precision Cancer Medicine  
2020;
3:
6  
Review Article 
Non-small cell lung cancer targetable mutations: present and future
Peter Vu, Sandip Pravin Patel
Precision Cancer Medicine  
2020;
3:
5  
Review Article 
Circulating tumor cells: moving forward into clinical applications
Zahra Eslami-S, Luis Enrique Cortés-Hernández, Catherine Alix-Panabières
Precision Cancer Medicine  
2020;
3:
4  
Original Article 
Significance of alectinib in anaplastic lymphoma kinase-tyrosine kinase inhibitors for anaplastic lymphoma kinase-positive patients with non–small cell lung cancer
Yasuhiro Chikaishi, Kenichi Kobayashi, Hiroki Matsumiya, Akihiro Taira, Yusuke Nabe, Shinji Shinohara, Taiji Kuwata, Masaru Takenaka, Soichi Oka, Ayako Hirai, Kouji Kuroda, Naoko Imanishi, Yoshinobu Ichiki, Fumihiro Tanaka
Precision Cancer Medicine  
2020;
3:
3  
Editorial 
Sharing data: a requirement for expanding precision oncology
Olivier Trédan
Precision Cancer Medicine  
2020;
3:
2  
Editorial 
The current and future revolution in lung cancer screening and management
Waleed Kian, Nadav Wallach, Nir Peled
Precision Cancer Medicine  
2020;
3:
1  
Editorial 
How to add value to research?
Peter Kapitein
Precision Cancer Medicine  
2019;
2:
39  
Editorial Commentary 
Immunotherapy approaches to beat tumors
Alexandre Morrot
Precision Cancer Medicine  
2019;
2:
38  
Editorial 
Precision surgery, it matters
Marcelo Jimenez
Precision Cancer Medicine  
2019;
2:
37  
Review Article 
How to recognize and manage hyper-progression and pseudo-progression during immune checkpoint blockade in non-small cell lung cancer
Francesco Facchinetti, Giuseppe Lo Russo, Marcello Tiseo, Marina Chiara Garassino, Roberto Ferrara
Precision Cancer Medicine  
2019;
2:
35  
Review Article 
Lung cancer screening: where do we stand?
Fabrizio Minervini, Marco Scarci
Precision Cancer Medicine  
2019;
2:
34  
Review Article 
Precision medicine and future of cancer treatment
Chandrajit Lahiri, Shrikant Pawar, Rohit Mishra
Precision Cancer Medicine  
2019;
2:
33  
News 
Application of the CARE guideline as reporting standard in the Precision Cancer Medicine
Editorial Office
Precision Cancer Medicine  
2019;
2:
32  
Original Article 
Differences in optimal timing of post-surgical surveillance for limited stage lung cancer patients and associations with outcomes
Elizabeth Colwell, Jalen Benson, Prasha Bhandari, Hao He, Joseph Shrager, Natalie Lui, Mark Berry, Leah Backhus
Precision Cancer Medicine  
2019;
2:
31  
Original Article 
Data sharing in the era of precision medicine: a scientometric analysis
Vincent Le Texier, Nesrine Henda, Stéphanie Cox, Marina ousseau-Tsangaris, Pierre Saintigny
Precision Cancer Medicine  
2019;
2:
30  
Currently no content available!

Editorial

AR-V7 and treatment selection in advanced prostate cancer: are we there yet?
Diogo A. Bastos, Emmanuel S. Antonarakis